The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effectiveness of anti-B-cell maturation antigen (BCMA)-targeting therapy after selinexor treatment.
 
Muhamed Baljevic
Honoraria - Curio Science; MJH Life Sciences; National Comprehensive Cancer Network; Targeted Oncology
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene; Cardinal Health; Genzyme; Janssen; Karyopharm Therapeutics
Other Relationship - GlaxoSmithKline
 
Philippe Moreau
Honoraria - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; oncopeptides; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen; oncopeptides; Sanofi
 
Sascha Alexander Tuchman
Honoraria - Janssen; Shattuck Labs
Speakers' Bureau - Celgene
Research Funding - Abbvie (Inst); Bristol-Myers Squibb/Celgene (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Sanofi (Inst)
 
Natalie Scott Callander
No Relationships to Disclose
 
Suzanne Lentzsch
Leadership - Caelum Biosciences
Stock and Other Ownership Interests - Caelum Biosciences
Consulting or Advisory Role - Adaptive Biotechnologies; BMS; GlaxoSmithKline; Janssen; Natera; Oncopeptides; Pfizer; Sanofi; Takeda
Speakers' Bureau - BioAscent; Clinical Care Options; PeerView; RedMedEd.com
Research Funding - Sanofi
Patents, Royalties, Other Intellectual Property - Patent 11-1F4 mAb for use in AL Amyloidosis
 
Dane R. Van Domelen
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
 
Ohad S. Bentur
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
 
Jorge Monge
Consulting or Advisory Role - Bristol-Myers Squibb
 
Noa Biran
Honoraria - Abbvie; Bristol-Myers Squibb; Janssen Oncology; Karyopharm Therapeutics; Pfizer
Consulting or Advisory Role - Pfizer; Sanofi/Aventis
Speakers' Bureau - Bristol-Myers Squibb; Janssen
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Karyopharm Therapeutics (Inst)